OK Biotech Company Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
62
- Stock Symbol
-
4155
- Investments
-
1
- Share Price
-
$0.56
- (As of Tuesday Closing)
OK Biotech Company General Information
Description
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
Contact Information
Website
www.okbiotech.comCorporate Office
- 6/F, Fo Tan Industrial Centre
- 26-28 Au Pui Wan Street
- Hong Kong
- Hong Kong
Corporate Office
- 6/F, Fo Tan Industrial Centre
- 26-28 Au Pui Wan Street
- Hong Kong
- Hong Kong
OK Biotech Company Stock Performance
As of 17-Nov-2026, OK Biotech Company’s stock price is $0.56. Its current market cap is $65.9M with 117M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.56 | $0.53 | $0.45 - $0.58 | $65.9M | 117M | 670K | $0.06 |
OK Biotech Company Financials Summary
As of 30-Sep-2026, OK Biotech Company has a trailing 12-month revenue of $54.6M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 82,588 | 95,595 | 103,548 | 113,895 |
| Revenue | 54,556 | 49,888 | 52,041 | 38,268 |
| EBITDA | 13,396 | 6,571 | 6,222 | 2,742 |
| Net Income | 7,949 | 2,643 | 2,928 | 95 |
| Total Assets | 130,104 | 123,089 | 112,374 | 99,823 |
| Total Debt | 33,861 | 33,062 | 23,702 | 10,836 |
OK Biotech Company Patents
OK Biotech Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2021107207-A | Sight-seeing bus | Active | 03-Sep-2019 | ||
| JP-3225733-U | Sightseeing bus | Inactive | 03-Sep-2019 | ||
| JP-6968459-B2 | Sightseeing bus | Inactive | 03-Sep-2019 | ||
| AU-2020217343-A1 | Tour bus | Active | 03-Sep-2019 | ||
| AU-2020217343-B2 | Tour bus | Inactive | 03-Sep-2019 | B62D47/02 |
OK Biotech Company Signals
OK Biotech Company Investments (1)
OK Biotech Company’s most recent deal was a Secondary Transaction - Private with Prodigy Diabetes Care for . The deal was made on 16-Apr-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Prodigy Diabetes Care | 16-Apr-2013 | Secondary Transaction - Private | Diagnostic Equipment |
OK Biotech Company ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
OK Biotech Company FAQs
-
When was OK Biotech Company founded?
OK Biotech Company was founded in 2006.
-
Where is OK Biotech Company headquartered?
OK Biotech Company is headquartered in Hong Kong, Hong Kong.
-
What is the size of OK Biotech Company?
OK Biotech Company has 62 total employees.
-
What industry is OK Biotech Company in?
OK Biotech Company’s primary industry is Diagnostic Equipment.
-
Is OK Biotech Company a private or public company?
OK Biotech Company is a Public company.
-
What is OK Biotech Company’s stock symbol?
The ticker symbol for OK Biotech Company is 4155.
-
What is the current stock price of OK Biotech Company?
As of 17-Nov-2026 the stock price of OK Biotech Company is $0.56.
-
What is the current market cap of OK Biotech Company?
The current market capitalization of OK Biotech Company is $65.9M.
-
What is OK Biotech Company’s current revenue?
The trailing twelve month revenue for OK Biotech Company is $54.6M.
-
What is OK Biotech Company’s annual earnings per share (EPS)?
OK Biotech Company’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process